nodes	percent_of_prediction	percent_of_DWPC	metapath
Vincristine—kidney cancer—melanoma	0.226	0.512	CtDrD
Vincristine—sarcoma—melanoma	0.215	0.488	CtDrD
Vincristine—ABCB1—melanoma	0.0378	1	CbGaD
Vincristine—TUBB6—Docetaxel—melanoma	0.031	0.0795	CbGbCtD
Vincristine—TUBB8—Docetaxel—melanoma	0.031	0.0795	CbGbCtD
Vincristine—TUBB2B—Docetaxel—melanoma	0.031	0.0795	CbGbCtD
Vincristine—TUBB2A—Docetaxel—melanoma	0.031	0.0795	CbGbCtD
Vincristine—TUBB4A—Docetaxel—melanoma	0.031	0.0795	CbGbCtD
Vincristine—TUBB3—Docetaxel—melanoma	0.031	0.0795	CbGbCtD
Vincristine—TUBB—Docetaxel—melanoma	0.0259	0.0665	CbGbCtD
Vincristine—TUBB1—Docetaxel—melanoma	0.0259	0.0665	CbGbCtD
Vincristine—TUBB4B—Docetaxel—melanoma	0.0259	0.0665	CbGbCtD
Vincristine—ABCC1—Vemurafenib—melanoma	0.0223	0.0572	CbGbCtD
Vincristine—ABCC10—Docetaxel—melanoma	0.0198	0.0508	CbGbCtD
Vincristine—ABCG2—Vemurafenib—melanoma	0.0149	0.0383	CbGbCtD
Vincristine—ABCC1—Dactinomycin—melanoma	0.0148	0.038	CbGbCtD
Vincristine—ABCG2—Dactinomycin—melanoma	0.0099	0.0254	CbGbCtD
Vincristine—ABCC1—Docetaxel—melanoma	0.00764	0.0196	CbGbCtD
Vincristine—CYP3A4—Temozolomide—melanoma	0.00587	0.0151	CbGbCtD
Vincristine—ABCC2—Docetaxel—melanoma	0.00565	0.0145	CbGbCtD
Vincristine—ABCG2—Docetaxel—melanoma	0.00511	0.0131	CbGbCtD
Vincristine—CYP3A7—Docetaxel—melanoma	0.00378	0.00969	CbGbCtD
Vincristine—CYP3A7-CYP3A51P—Docetaxel—melanoma	0.00378	0.00969	CbGbCtD
Vincristine—ABCB1—Dactinomycin—melanoma	0.00357	0.00917	CbGbCtD
Vincristine—CYP3A4—Vemurafenib—melanoma	0.00322	0.00826	CbGbCtD
Vincristine—CYP3A5—Docetaxel—melanoma	0.00283	0.00727	CbGbCtD
Vincristine—ABCB1—Docetaxel—melanoma	0.00184	0.00473	CbGbCtD
Vincristine—CYP3A4—Docetaxel—melanoma	0.0011	0.00284	CbGbCtD
Vincristine—RALBP1—hair follicle—melanoma	0.000927	0.0516	CbGeAlD
Vincristine—TUBB4B—skin epidermis—melanoma	0.000861	0.048	CbGeAlD
Vincristine—TUBB—hair follicle—melanoma	0.000721	0.0402	CbGeAlD
Vincristine—TUBB4B—hair follicle—melanoma	0.000615	0.0342	CbGeAlD
Vincristine—TUBB8—head—melanoma	0.000538	0.03	CbGeAlD
Vincristine—TUBA4A—eye—melanoma	0.000491	0.0273	CbGeAlD
Vincristine—TUBA4A—retina—melanoma	0.000486	0.0271	CbGeAlD
Vincristine—RALBP1—eye—melanoma	0.000462	0.0258	CbGeAlD
Vincristine—RALBP1—retina—melanoma	0.000458	0.0255	CbGeAlD
Vincristine—ABCC1—hair follicle—melanoma	0.000438	0.0244	CbGeAlD
Vincristine—TUBA4A—skin of body—melanoma	0.000427	0.0238	CbGeAlD
Vincristine—TUBB4A—eye—melanoma	0.000393	0.0219	CbGeAlD
Vincristine—TUBB4A—retina—melanoma	0.00039	0.0217	CbGeAlD
Vincristine—TUBA4A—mammalian vulva—melanoma	0.000389	0.0217	CbGeAlD
Vincristine—TUBB2B—eye—melanoma	0.00038	0.0212	CbGeAlD
Vincristine—TUBB2B—retina—melanoma	0.000377	0.021	CbGeAlD
Vincristine—RALBP1—mammalian vulva—melanoma	0.000367	0.0204	CbGeAlD
Vincristine—TUBB3—head—melanoma	0.000367	0.0204	CbGeAlD
Vincristine—TUBB1—head—melanoma	0.000359	0.02	CbGeAlD
Vincristine—TUBB2A—eye—melanoma	0.000358	0.0199	CbGeAlD
Vincristine—TUBB4A—skin of body—melanoma	0.000342	0.0191	CbGeAlD
Vincristine—TUBB2A—skin of body—melanoma	0.000311	0.0173	CbGeAlD
Vincristine—TUBB6—skin of body—melanoma	0.000307	0.0171	CbGeAlD
Vincristine—TUBB4B—eye—melanoma	0.000307	0.0171	CbGeAlD
Vincristine—TUBB4B—retina—melanoma	0.000304	0.0169	CbGeAlD
Vincristine—TUBB2B—mammalian vulva—melanoma	0.000302	0.0168	CbGeAlD
Vincristine—TUBB—mammalian vulva—melanoma	0.000285	0.0159	CbGeAlD
Vincristine—TUBB2A—mammalian vulva—melanoma	0.000284	0.0158	CbGeAlD
Vincristine—Voacamine—ABCB1—melanoma	0.000283	0.55	CrCbGaD
Vincristine—TUBB6—mammalian vulva—melanoma	0.00028	0.0156	CbGeAlD
Vincristine—TUBA4A—head—melanoma	0.000279	0.0155	CbGeAlD
Vincristine—Neuropathy—Temozolomide—melanoma	0.000275	0.00488	CcSEcCtD
Vincristine—Cardiac disorder—Vemurafenib—melanoma	0.000267	0.00474	CcSEcCtD
Vincristine—TUBB4B—skin of body—melanoma	0.000267	0.0149	CbGeAlD
Vincristine—RALBP1—head—melanoma	0.000263	0.0146	CbGeAlD
Vincristine—Hepatic failure—Dactinomycin—melanoma	0.000261	0.00464	CcSEcCtD
Vincristine—Angiopathy—Vemurafenib—melanoma	0.000261	0.00463	CcSEcCtD
Vincristine—Neuritis—Docetaxel—melanoma	0.000261	0.00463	CcSEcCtD
Vincristine—Mediastinal disorder—Vemurafenib—melanoma	0.000259	0.0046	CcSEcCtD
Vincristine—Alopecia—Vemurafenib—melanoma	0.000254	0.00451	CcSEcCtD
Vincristine—ABCC10—mammalian vulva—melanoma	0.000245	0.0137	CbGeAlD
Vincristine—TUBB4B—mammalian vulva—melanoma	0.000243	0.0136	CbGeAlD
Vincristine—Back pain—Vemurafenib—melanoma	0.000242	0.0043	CcSEcCtD
Vincristine—Deafness—Temozolomide—melanoma	0.000238	0.00422	CcSEcCtD
Vincristine—Hepatic failure—Temozolomide—melanoma	0.000236	0.0042	CcSEcCtD
Vincristine—TUBB4A—head—melanoma	0.000223	0.0124	CbGeAlD
Vincristine—Extravasation—Docetaxel—melanoma	0.000223	0.00396	CcSEcCtD
Vincristine—Hyponatraemia—Carmustine—melanoma	0.000221	0.00392	CcSEcCtD
Vincristine—TUBB2B—head—melanoma	0.000216	0.012	CbGeAlD
Vincristine—Myalgia—Vemurafenib—melanoma	0.000213	0.00378	CcSEcCtD
Vincristine—Aspartate aminotransferase increased—Dactinomycin—melanoma	0.000212	0.00376	CcSEcCtD
Vincristine—Drug interaction—Docetaxel—melanoma	0.00021	0.00372	CcSEcCtD
Vincristine—SLC22A3—mammalian vulva—melanoma	0.00021	0.0117	CbGeAlD
Vincristine—Pancytopenia—Bleomycin—melanoma	0.000207	0.00367	CcSEcCtD
Vincristine—Ataxia—Carmustine—melanoma	0.000207	0.00367	CcSEcCtD
Vincristine—Anaphylactic shock—Vemurafenib—melanoma	0.000204	0.00363	CcSEcCtD
Vincristine—Bone pain—Docetaxel—melanoma	0.000203	0.00361	CcSEcCtD
Vincristine—TUBB2A—head—melanoma	0.000203	0.0113	CbGeAlD
Vincristine—Infection—Vemurafenib—melanoma	0.000203	0.0036	CcSEcCtD
Vincristine—Nervous system disorder—Vemurafenib—melanoma	0.0002	0.00356	CcSEcCtD
Vincristine—TUBB6—head—melanoma	0.0002	0.0112	CbGeAlD
Vincristine—Ataxia—Temozolomide—melanoma	0.0002	0.00355	CcSEcCtD
Vincristine—Respiratory failure—Docetaxel—melanoma	0.000198	0.00352	CcSEcCtD
Vincristine—Dehydration—Temozolomide—melanoma	0.000198	0.00351	CcSEcCtD
Vincristine—Weight decreased—Bleomycin—melanoma	0.000197	0.0035	CcSEcCtD
Vincristine—Pneumonia—Bleomycin—melanoma	0.000195	0.00347	CcSEcCtD
Vincristine—TUBA4A—lymph node—melanoma	0.000195	0.0109	CbGeAlD
Vincristine—Muscular weakness—Carmustine—melanoma	0.000194	0.00344	CcSEcCtD
Vincristine—Pancytopenia—Dactinomycin—melanoma	0.000193	0.00342	CcSEcCtD
Vincristine—Acute coronary syndrome—Bleomycin—melanoma	0.000191	0.0034	CcSEcCtD
Vincristine—Aspartate aminotransferase increased—Temozolomide—melanoma	0.000191	0.0034	CcSEcCtD
Vincristine—Hypotension—Vemurafenib—melanoma	0.000191	0.00339	CcSEcCtD
Vincristine—Myocardial infarction—Bleomycin—melanoma	0.00019	0.00338	CcSEcCtD
Vincristine—Neutropenia—Dactinomycin—melanoma	0.00019	0.00337	CcSEcCtD
Vincristine—Stomatitis—Bleomycin—melanoma	0.000189	0.00336	CcSEcCtD
Vincristine—Muscular weakness—Temozolomide—melanoma	0.000187	0.00333	CcSEcCtD
Vincristine—Musculoskeletal discomfort—Vemurafenib—melanoma	0.000186	0.0033	CcSEcCtD
Vincristine—RALBP1—lymph node—melanoma	0.000184	0.0102	CbGeAlD
Vincristine—Neuropathy—Docetaxel—melanoma	0.000183	0.00324	CcSEcCtD
Vincristine—Pneumonia—Dactinomycin—melanoma	0.000182	0.00323	CcSEcCtD
Vincristine—Pancytopenia—Carmustine—melanoma	0.00018	0.0032	CcSEcCtD
Vincristine—Neutropenia—Carmustine—melanoma	0.000178	0.00315	CcSEcCtD
Vincristine—Decreased appetite—Vemurafenib—melanoma	0.000178	0.00315	CcSEcCtD
Vincristine—Stomatitis—Dactinomycin—melanoma	0.000176	0.00313	CcSEcCtD
Vincristine—Gastrointestinal disorder—Vemurafenib—melanoma	0.000176	0.00313	CcSEcCtD
Vincristine—ABCC3—head—melanoma	0.000176	0.00982	CbGeAlD
Vincristine—Fatigue—Vemurafenib—melanoma	0.000176	0.00313	CcSEcCtD
Vincristine—Constipation—Vemurafenib—melanoma	0.000175	0.0031	CcSEcCtD
Vincristine—Pancytopenia—Temozolomide—melanoma	0.000174	0.0031	CcSEcCtD
Vincristine—TUBB4B—head—melanoma	0.000174	0.0097	CbGeAlD
Vincristine—ABCC1—mammalian vulva—melanoma	0.000173	0.00966	CbGeAlD
Vincristine—Hypoaesthesia—Bleomycin—melanoma	0.000173	0.00308	CcSEcCtD
Vincristine—Dysuria—Temozolomide—melanoma	0.000172	0.00305	CcSEcCtD
Vincristine—Neutropenia—Temozolomide—melanoma	0.000172	0.00305	CcSEcCtD
Vincristine—Pneumonia—Carmustine—melanoma	0.00017	0.00303	CcSEcCtD
Vincristine—Erectile dysfunction—Temozolomide—melanoma	0.000169	0.003	CcSEcCtD
Vincristine—Depression—Carmustine—melanoma	0.000169	0.003	CcSEcCtD
Vincristine—ABCB1—blood vessel—melanoma	0.000168	0.00934	CbGeAlD
Vincristine—Photosensitivity reaction—Temozolomide—melanoma	0.000168	0.00298	CcSEcCtD
Vincristine—Weight decreased—Temozolomide—melanoma	0.000166	0.00295	CcSEcCtD
Vincristine—Neuropathy peripheral—Carmustine—melanoma	0.000166	0.00295	CcSEcCtD
Vincristine—Stomatitis—Carmustine—melanoma	0.000165	0.00293	CcSEcCtD
Vincristine—Pneumonia—Temozolomide—melanoma	0.000165	0.00292	CcSEcCtD
Vincristine—Depression—Temozolomide—melanoma	0.000163	0.0029	CcSEcCtD
Vincristine—Body temperature increased—Vemurafenib—melanoma	0.000162	0.00287	CcSEcCtD
Vincristine—Neuropathy peripheral—Temozolomide—melanoma	0.00016	0.00285	CcSEcCtD
Vincristine—Stomatitis—Temozolomide—melanoma	0.00016	0.00283	CcSEcCtD
Vincristine—Deafness—Docetaxel—melanoma	0.000158	0.0028	CcSEcCtD
Vincristine—Hepatic failure—Docetaxel—melanoma	0.000157	0.00279	CcSEcCtD
Vincristine—TUBB4A—lymph node—melanoma	0.000156	0.00871	CbGeAlD
Vincristine—Alopecia—Bleomycin—melanoma	0.000154	0.00273	CcSEcCtD
Vincristine—Hypoaesthesia—Carmustine—melanoma	0.000151	0.00269	CcSEcCtD
Vincristine—Hallucination—Carmustine—melanoma	0.000151	0.00269	CcSEcCtD
Vincristine—TUBB2B—lymph node—melanoma	0.000151	0.00842	CbGeAlD
Vincristine—Hypersensitivity—Vemurafenib—melanoma	0.000151	0.00267	CcSEcCtD
Vincristine—SLC22A3—head—melanoma	0.00015	0.00836	CbGeAlD
Vincristine—Connective tissue disorder—Carmustine—melanoma	0.000149	0.00265	CcSEcCtD
Vincristine—Asthenia—Vemurafenib—melanoma	0.000147	0.0026	CcSEcCtD
Vincristine—Hallucination—Temozolomide—melanoma	0.000146	0.0026	CcSEcCtD
Vincristine—Hypoaesthesia—Temozolomide—melanoma	0.000146	0.0026	CcSEcCtD
Vincristine—Urinary tract disorder—Temozolomide—melanoma	0.000145	0.00258	CcSEcCtD
Vincristine—Connective tissue disorder—Temozolomide—melanoma	0.000144	0.00256	CcSEcCtD
Vincristine—Urethral disorder—Temozolomide—melanoma	0.000144	0.00256	CcSEcCtD
Vincristine—Alopecia—Dactinomycin—melanoma	0.000144	0.00255	CcSEcCtD
Vincristine—ABCG2—mammalian vulva—melanoma	0.000144	0.008	CbGeAlD
Vincristine—TUBB—lymph node—melanoma	0.000143	0.00797	CbGeAlD
Vincristine—TUBB2A—lymph node—melanoma	0.000142	0.00792	CbGeAlD
Vincristine—Hyponatraemia—Docetaxel—melanoma	0.000142	0.00252	CcSEcCtD
Vincristine—Pain in extremity—Docetaxel—melanoma	0.000141	0.00251	CcSEcCtD
Vincristine—TUBB6—lymph node—melanoma	0.00014	0.00781	CbGeAlD
Vincristine—Anaemia—Bleomycin—melanoma	0.00014	0.00249	CcSEcCtD
Vincristine—Diarrhoea—Vemurafenib—melanoma	0.00014	0.00248	CcSEcCtD
Vincristine—Cardiac disorder—Temozolomide—melanoma	0.000136	0.00242	CcSEcCtD
Vincristine—Leukopenia—Bleomycin—melanoma	0.000136	0.00241	CcSEcCtD
Vincristine—Dizziness—Vemurafenib—melanoma	0.000135	0.0024	CcSEcCtD
Vincristine—Alopecia—Carmustine—melanoma	0.000134	0.00239	CcSEcCtD
Vincristine—Angiopathy—Temozolomide—melanoma	0.000133	0.00237	CcSEcCtD
Vincristine—Mental disorder—Carmustine—melanoma	0.000133	0.00237	CcSEcCtD
Vincristine—Ataxia—Docetaxel—melanoma	0.000133	0.00236	CcSEcCtD
Vincristine—Mediastinal disorder—Temozolomide—melanoma	0.000132	0.00235	CcSEcCtD
Vincristine—Dehydration—Docetaxel—melanoma	0.000131	0.00233	CcSEcCtD
Vincristine—Vinorelbine—ABCB1—melanoma	0.000131	0.254	CrCbGaD
Vincristine—Anaemia—Dactinomycin—melanoma	0.000131	0.00232	CcSEcCtD
Vincristine—Vomiting—Vemurafenib—melanoma	0.00013	0.00231	CcSEcCtD
Vincristine—Alopecia—Temozolomide—melanoma	0.00013	0.00231	CcSEcCtD
Vincristine—Myalgia—Bleomycin—melanoma	0.000129	0.00229	CcSEcCtD
Vincristine—Rash—Vemurafenib—melanoma	0.000129	0.00229	CcSEcCtD
Vincristine—Mental disorder—Temozolomide—melanoma	0.000129	0.00229	CcSEcCtD
Vincristine—Dermatitis—Vemurafenib—melanoma	0.000129	0.00228	CcSEcCtD
Vincristine—Back pain—Carmustine—melanoma	0.000128	0.00227	CcSEcCtD
Vincristine—Headache—Vemurafenib—melanoma	0.000128	0.00227	CcSEcCtD
Vincristine—Aspartate aminotransferase increased—Docetaxel—melanoma	0.000127	0.00226	CcSEcCtD
Vincristine—Leukopenia—Dactinomycin—melanoma	0.000127	0.00225	CcSEcCtD
Vincristine—Anaphylactic shock—Bleomycin—melanoma	0.000124	0.0022	CcSEcCtD
Vincristine—Oedema—Bleomycin—melanoma	0.000124	0.0022	CcSEcCtD
Vincristine—Back pain—Temozolomide—melanoma	0.000124	0.0022	CcSEcCtD
Vincristine—ABCC3—lymph node—melanoma	0.000123	0.00688	CbGeAlD
Vincristine—Infection—Bleomycin—melanoma	0.000123	0.00218	CcSEcCtD
Vincristine—ABCC10—lymph node—melanoma	0.000123	0.00684	CbGeAlD
Vincristine—Anaemia—Carmustine—melanoma	0.000122	0.00217	CcSEcCtD
Vincristine—TUBB4B—lymph node—melanoma	0.000122	0.00679	CbGeAlD
Vincristine—Agitation—Carmustine—melanoma	0.000122	0.00216	CcSEcCtD
Vincristine—Nausea—Vemurafenib—melanoma	0.000121	0.00215	CcSEcCtD
Vincristine—Thrombocytopenia—Bleomycin—melanoma	0.000121	0.00215	CcSEcCtD
Vincristine—Myalgia—Dactinomycin—melanoma	0.00012	0.00214	CcSEcCtD
Vincristine—Leukopenia—Carmustine—melanoma	0.000119	0.0021	CcSEcCtD
Vincristine—Anaemia—Temozolomide—melanoma	0.000118	0.0021	CcSEcCtD
Vincristine—Anorexia—Bleomycin—melanoma	0.000118	0.00209	CcSEcCtD
Vincristine—Agitation—Temozolomide—melanoma	0.000118	0.00209	CcSEcCtD
Vincristine—Pancytopenia—Docetaxel—melanoma	0.000116	0.00206	CcSEcCtD
Vincristine—Hypotension—Bleomycin—melanoma	0.000116	0.00205	CcSEcCtD
Vincristine—Oedema—Dactinomycin—melanoma	0.000115	0.00205	CcSEcCtD
Vincristine—Vertigo—Temozolomide—melanoma	0.000115	0.00204	CcSEcCtD
Vincristine—Convulsion—Carmustine—melanoma	0.000115	0.00204	CcSEcCtD
Vincristine—Infection—Dactinomycin—melanoma	0.000115	0.00204	CcSEcCtD
Vincristine—Leukopenia—Temozolomide—melanoma	0.000115	0.00203	CcSEcCtD
Vincristine—Hypertension—Carmustine—melanoma	0.000114	0.00203	CcSEcCtD
Vincristine—Neutropenia—Docetaxel—melanoma	0.000114	0.00203	CcSEcCtD
Vincristine—Thrombocytopenia—Dactinomycin—melanoma	0.000113	0.00201	CcSEcCtD
Vincristine—Musculoskeletal discomfort—Bleomycin—melanoma	0.000113	0.002	CcSEcCtD
Vincristine—Myalgia—Carmustine—melanoma	0.000113	0.002	CcSEcCtD
Vincristine—Paraesthesia—Bleomycin—melanoma	0.000111	0.00197	CcSEcCtD
Vincristine—Convulsion—Temozolomide—melanoma	0.000111	0.00197	CcSEcCtD
Vincristine—Weight decreased—Docetaxel—melanoma	0.00011	0.00196	CcSEcCtD
Vincristine—Hypertension—Temozolomide—melanoma	0.00011	0.00196	CcSEcCtD
Vincristine—Anorexia—Dactinomycin—melanoma	0.00011	0.00195	CcSEcCtD
Vincristine—Pneumonia—Docetaxel—melanoma	0.00011	0.00194	CcSEcCtD
Vincristine—Myalgia—Temozolomide—melanoma	0.000109	0.00193	CcSEcCtD
Vincristine—Oedema—Carmustine—melanoma	0.000108	0.00192	CcSEcCtD
Vincristine—Decreased appetite—Bleomycin—melanoma	0.000108	0.00191	CcSEcCtD
Vincristine—Infection—Carmustine—melanoma	0.000107	0.00191	CcSEcCtD
Vincristine—Acute coronary syndrome—Docetaxel—melanoma	0.000107	0.00191	CcSEcCtD
Vincristine—Myocardial infarction—Docetaxel—melanoma	0.000107	0.00189	CcSEcCtD
Vincristine—Neuropathy peripheral—Docetaxel—melanoma	0.000107	0.00189	CcSEcCtD
Vincristine—Stomatitis—Docetaxel—melanoma	0.000106	0.00188	CcSEcCtD
Vincristine—Pain—Bleomycin—melanoma	0.000106	0.00188	CcSEcCtD
Vincristine—Thrombocytopenia—Carmustine—melanoma	0.000106	0.00188	CcSEcCtD
Vincristine—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000105	0.00187	CcSEcCtD
Vincristine—SLC22A3—lymph node—melanoma	0.000105	0.00585	CbGeAlD
Vincristine—Oedema—Temozolomide—melanoma	0.000104	0.00185	CcSEcCtD
Vincristine—Anaphylactic shock—Temozolomide—melanoma	0.000104	0.00185	CcSEcCtD
Vincristine—Infection—Temozolomide—melanoma	0.000104	0.00184	CcSEcCtD
Vincristine—Anorexia—Carmustine—melanoma	0.000103	0.00183	CcSEcCtD
Vincristine—Nervous system disorder—Temozolomide—melanoma	0.000102	0.00182	CcSEcCtD
Vincristine—Thrombocytopenia—Temozolomide—melanoma	0.000102	0.00182	CcSEcCtD
Vincristine—Hypotension—Carmustine—melanoma	0.000101	0.00179	CcSEcCtD
Vincristine—Hyperhidrosis—Temozolomide—melanoma	0.000101	0.00179	CcSEcCtD
Vincristine—Vinblastine—ABCB1—melanoma	0.000101	0.196	CrCbGaD
Vincristine—Decreased appetite—Dactinomycin—melanoma	0.0001	0.00178	CcSEcCtD
Vincristine—Fatigue—Dactinomycin—melanoma	9.95e-05	0.00177	CcSEcCtD
Vincristine—Anorexia—Temozolomide—melanoma	9.95e-05	0.00177	CcSEcCtD
Vincristine—Pain—Dactinomycin—melanoma	9.87e-05	0.00175	CcSEcCtD
Vincristine—ABCC2—lymph node—melanoma	9.86e-05	0.00549	CbGeAlD
Vincristine—Musculoskeletal discomfort—Carmustine—melanoma	9.84e-05	0.00175	CcSEcCtD
Vincristine—Body temperature increased—Bleomycin—melanoma	9.79e-05	0.00174	CcSEcCtD
Vincristine—Insomnia—Carmustine—melanoma	9.77e-05	0.00173	CcSEcCtD
Vincristine—Hypoaesthesia—Docetaxel—melanoma	9.73e-05	0.00173	CcSEcCtD
Vincristine—Paraesthesia—Carmustine—melanoma	9.7e-05	0.00172	CcSEcCtD
Vincristine—Urinary tract disorder—Docetaxel—melanoma	9.65e-05	0.00171	CcSEcCtD
Vincristine—Connective tissue disorder—Docetaxel—melanoma	9.61e-05	0.00171	CcSEcCtD
Vincristine—Urethral disorder—Docetaxel—melanoma	9.58e-05	0.0017	CcSEcCtD
Vincristine—Musculoskeletal discomfort—Temozolomide—melanoma	9.51e-05	0.00169	CcSEcCtD
Vincristine—Insomnia—Temozolomide—melanoma	9.44e-05	0.00168	CcSEcCtD
Vincristine—Gastrointestinal pain—Dactinomycin—melanoma	9.44e-05	0.00168	CcSEcCtD
Vincristine—Decreased appetite—Carmustine—melanoma	9.39e-05	0.00167	CcSEcCtD
Vincristine—Paraesthesia—Temozolomide—melanoma	9.38e-05	0.00166	CcSEcCtD
Vincristine—Gastrointestinal disorder—Carmustine—melanoma	9.33e-05	0.00166	CcSEcCtD
Vincristine—Constipation—Carmustine—melanoma	9.24e-05	0.00164	CcSEcCtD
Vincristine—Pain—Carmustine—melanoma	9.24e-05	0.00164	CcSEcCtD
Vincristine—Abdominal pain—Dactinomycin—melanoma	9.13e-05	0.00162	CcSEcCtD
Vincristine—Body temperature increased—Dactinomycin—melanoma	9.13e-05	0.00162	CcSEcCtD
Vincristine—Hypersensitivity—Bleomycin—melanoma	9.12e-05	0.00162	CcSEcCtD
Vincristine—Decreased appetite—Temozolomide—melanoma	9.08e-05	0.00161	CcSEcCtD
Vincristine—Cardiac disorder—Docetaxel—melanoma	9.07e-05	0.00161	CcSEcCtD
Vincristine—Gastrointestinal disorder—Temozolomide—melanoma	9.02e-05	0.0016	CcSEcCtD
Vincristine—Fatigue—Temozolomide—melanoma	9e-05	0.0016	CcSEcCtD
Vincristine—Pain—Temozolomide—melanoma	8.93e-05	0.00159	CcSEcCtD
Vincristine—Constipation—Temozolomide—melanoma	8.93e-05	0.00159	CcSEcCtD
Vincristine—Asthenia—Bleomycin—melanoma	8.88e-05	0.00158	CcSEcCtD
Vincristine—Angiopathy—Docetaxel—melanoma	8.87e-05	0.00157	CcSEcCtD
Vincristine—ABCB1—retina—melanoma	8.84e-05	0.00493	CbGeAlD
Vincristine—Gastrointestinal pain—Carmustine—melanoma	8.84e-05	0.00157	CcSEcCtD
Vincristine—Mediastinal disorder—Docetaxel—melanoma	8.81e-05	0.00156	CcSEcCtD
Vincristine—ABCC1—lymph node—melanoma	8.69e-05	0.00484	CbGeAlD
Vincristine—Alopecia—Docetaxel—melanoma	8.64e-05	0.00153	CcSEcCtD
Vincristine—Mental disorder—Docetaxel—melanoma	8.56e-05	0.00152	CcSEcCtD
Vincristine—Body temperature increased—Carmustine—melanoma	8.54e-05	0.00152	CcSEcCtD
Vincristine—Abdominal pain—Carmustine—melanoma	8.54e-05	0.00152	CcSEcCtD
Vincristine—Gastrointestinal pain—Temozolomide—melanoma	8.54e-05	0.00152	CcSEcCtD
Vincristine—Hypersensitivity—Dactinomycin—melanoma	8.51e-05	0.00151	CcSEcCtD
Vincristine—Asthenia—Dactinomycin—melanoma	8.28e-05	0.00147	CcSEcCtD
Vincristine—Abdominal pain—Temozolomide—melanoma	8.25e-05	0.00147	CcSEcCtD
Vincristine—Body temperature increased—Temozolomide—melanoma	8.25e-05	0.00147	CcSEcCtD
Vincristine—Back pain—Docetaxel—melanoma	8.23e-05	0.00146	CcSEcCtD
Vincristine—Hypersensitivity—Carmustine—melanoma	7.96e-05	0.00141	CcSEcCtD
Vincristine—Diarrhoea—Dactinomycin—melanoma	7.9e-05	0.0014	CcSEcCtD
Vincristine—Vomiting—Bleomycin—melanoma	7.87e-05	0.0014	CcSEcCtD
Vincristine—Anaemia—Docetaxel—melanoma	7.86e-05	0.0014	CcSEcCtD
Vincristine—Rash—Bleomycin—melanoma	7.81e-05	0.00139	CcSEcCtD
Vincristine—Dermatitis—Bleomycin—melanoma	7.8e-05	0.00138	CcSEcCtD
Vincristine—Asthenia—Carmustine—melanoma	7.75e-05	0.00138	CcSEcCtD
Vincristine—Hypersensitivity—Temozolomide—melanoma	7.69e-05	0.00137	CcSEcCtD
Vincristine—Leukopenia—Docetaxel—melanoma	7.62e-05	0.00135	CcSEcCtD
Vincristine—Asthenia—Temozolomide—melanoma	7.49e-05	0.00133	CcSEcCtD
Vincristine—Diarrhoea—Carmustine—melanoma	7.39e-05	0.00131	CcSEcCtD
Vincristine—Convulsion—Docetaxel—melanoma	7.37e-05	0.00131	CcSEcCtD
Vincristine—Nausea—Bleomycin—melanoma	7.35e-05	0.00131	CcSEcCtD
Vincristine—Hypertension—Docetaxel—melanoma	7.35e-05	0.0013	CcSEcCtD
Vincristine—Vomiting—Dactinomycin—melanoma	7.34e-05	0.0013	CcSEcCtD
Vincristine—Rash—Dactinomycin—melanoma	7.28e-05	0.00129	CcSEcCtD
Vincristine—Myalgia—Docetaxel—melanoma	7.24e-05	0.00129	CcSEcCtD
Vincristine—ABCG2—lymph node—melanoma	7.19e-05	0.00401	CbGeAlD
Vincristine—Dizziness—Carmustine—melanoma	7.15e-05	0.00127	CcSEcCtD
Vincristine—Diarrhoea—Temozolomide—melanoma	7.14e-05	0.00127	CcSEcCtD
Vincristine—ABCB1—mammalian vulva—melanoma	7.08e-05	0.00394	CbGeAlD
Vincristine—Anaphylactic shock—Docetaxel—melanoma	6.94e-05	0.00123	CcSEcCtD
Vincristine—Oedema—Docetaxel—melanoma	6.94e-05	0.00123	CcSEcCtD
Vincristine—Dizziness—Temozolomide—melanoma	6.91e-05	0.00123	CcSEcCtD
Vincristine—Infection—Docetaxel—melanoma	6.9e-05	0.00122	CcSEcCtD
Vincristine—Vomiting—Carmustine—melanoma	6.87e-05	0.00122	CcSEcCtD
Vincristine—Nausea—Dactinomycin—melanoma	6.86e-05	0.00122	CcSEcCtD
Vincristine—Rash—Carmustine—melanoma	6.81e-05	0.00121	CcSEcCtD
Vincristine—Nervous system disorder—Docetaxel—melanoma	6.81e-05	0.00121	CcSEcCtD
Vincristine—Dermatitis—Carmustine—melanoma	6.81e-05	0.00121	CcSEcCtD
Vincristine—Thrombocytopenia—Docetaxel—melanoma	6.8e-05	0.00121	CcSEcCtD
Vincristine—Headache—Carmustine—melanoma	6.77e-05	0.0012	CcSEcCtD
Vincristine—Vomiting—Temozolomide—melanoma	6.64e-05	0.00118	CcSEcCtD
Vincristine—Anorexia—Docetaxel—melanoma	6.62e-05	0.00118	CcSEcCtD
Vincristine—Rash—Temozolomide—melanoma	6.58e-05	0.00117	CcSEcCtD
Vincristine—Dermatitis—Temozolomide—melanoma	6.58e-05	0.00117	CcSEcCtD
Vincristine—Headache—Temozolomide—melanoma	6.54e-05	0.00116	CcSEcCtD
Vincristine—Hypotension—Docetaxel—melanoma	6.49e-05	0.00115	CcSEcCtD
Vincristine—Nausea—Carmustine—melanoma	6.42e-05	0.00114	CcSEcCtD
Vincristine—Musculoskeletal discomfort—Docetaxel—melanoma	6.33e-05	0.00112	CcSEcCtD
Vincristine—Insomnia—Docetaxel—melanoma	6.28e-05	0.00111	CcSEcCtD
Vincristine—Paraesthesia—Docetaxel—melanoma	6.24e-05	0.00111	CcSEcCtD
Vincristine—Nausea—Temozolomide—melanoma	6.2e-05	0.0011	CcSEcCtD
Vincristine—Decreased appetite—Docetaxel—melanoma	6.04e-05	0.00107	CcSEcCtD
Vincristine—Gastrointestinal disorder—Docetaxel—melanoma	6e-05	0.00106	CcSEcCtD
Vincristine—Fatigue—Docetaxel—melanoma	5.99e-05	0.00106	CcSEcCtD
Vincristine—Pain—Docetaxel—melanoma	5.94e-05	0.00105	CcSEcCtD
Vincristine—Constipation—Docetaxel—melanoma	5.94e-05	0.00105	CcSEcCtD
Vincristine—Gastrointestinal pain—Docetaxel—melanoma	5.68e-05	0.00101	CcSEcCtD
Vincristine—Abdominal pain—Docetaxel—melanoma	5.49e-05	0.000975	CcSEcCtD
Vincristine—Body temperature increased—Docetaxel—melanoma	5.49e-05	0.000975	CcSEcCtD
Vincristine—Hypersensitivity—Docetaxel—melanoma	5.12e-05	0.000908	CcSEcCtD
Vincristine—ABCB1—head—melanoma	5.06e-05	0.00282	CbGeAlD
Vincristine—Asthenia—Docetaxel—melanoma	4.98e-05	0.000884	CcSEcCtD
Vincristine—Diarrhoea—Docetaxel—melanoma	4.75e-05	0.000843	CcSEcCtD
Vincristine—Dizziness—Docetaxel—melanoma	4.59e-05	0.000815	CcSEcCtD
Vincristine—Vomiting—Docetaxel—melanoma	4.42e-05	0.000784	CcSEcCtD
Vincristine—Rash—Docetaxel—melanoma	4.38e-05	0.000777	CcSEcCtD
Vincristine—Dermatitis—Docetaxel—melanoma	4.37e-05	0.000777	CcSEcCtD
Vincristine—Headache—Docetaxel—melanoma	4.35e-05	0.000772	CcSEcCtD
Vincristine—Nausea—Docetaxel—melanoma	4.12e-05	0.000732	CcSEcCtD
Vincristine—ABCB1—lymph node—melanoma	3.55e-05	0.00198	CbGeAlD
Vincristine—ABCC3—Metabolism—ABCB1—melanoma	3.89e-06	6.81e-05	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—CYP17A1—melanoma	3.87e-06	6.77e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—UGT2B10—melanoma	3.87e-06	6.77e-05	CbGpPWpGaD
Vincristine—SLC22A3—Metabolism—ERCC2—melanoma	3.87e-06	6.76e-05	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—CD44—melanoma	3.87e-06	6.76e-05	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—GNAQ—melanoma	3.87e-06	6.76e-05	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—melanoma	3.86e-06	6.75e-05	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—VEGFA—melanoma	3.86e-06	6.74e-05	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—CYP17A1—melanoma	3.84e-06	6.71e-05	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—melanoma	3.82e-06	6.68e-05	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—STAT3—melanoma	3.82e-06	6.68e-05	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—NRAS—melanoma	3.81e-06	6.66e-05	CbGpPWpGaD
Vincristine—ABCC1—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	3.78e-06	6.62e-05	CbGpPWpGaD
Vincristine—ABCC1—Disease—ERBB4—melanoma	3.76e-06	6.58e-05	CbGpPWpGaD
Vincristine—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—melanoma	3.75e-06	6.56e-05	CbGpPWpGaD
Vincristine—ABCB11—Metabolism—PRKCA—melanoma	3.74e-06	6.54e-05	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—melanoma	3.73e-06	6.53e-05	CbGpPWpGaD
Vincristine—ABCC1—Disease—CDKN2B—melanoma	3.73e-06	6.52e-05	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—melanoma	3.73e-06	6.51e-05	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—melanoma	3.71e-06	6.48e-05	CbGpPWpGaD
Vincristine—ABCB11—Metabolism—ERCC2—melanoma	3.71e-06	6.48e-05	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—CYP1B1—melanoma	3.71e-06	6.48e-05	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—PLA2G6—melanoma	3.66e-06	6.4e-05	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—GNA11—melanoma	3.66e-06	6.4e-05	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—MAPK3—melanoma	3.65e-06	6.38e-05	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—GNA11—melanoma	3.63e-06	6.34e-05	CbGpPWpGaD
Vincristine—TUBB4B—Cell Cycle—TP53—melanoma	3.62e-06	6.33e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—PHGDH—melanoma	3.61e-06	6.31e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—LUM—melanoma	3.61e-06	6.31e-05	CbGpPWpGaD
Vincristine—ABCC1—Disease—CD86—melanoma	3.61e-06	6.31e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—HS3ST5—melanoma	3.6e-06	6.29e-05	CbGpPWpGaD
Vincristine—ABCG2—Transmembrane transport of small molecules—ALB—melanoma	3.59e-06	6.27e-05	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—PRKCA—melanoma	3.58e-06	6.27e-05	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—FASN—melanoma	3.58e-06	6.26e-05	CbGpPWpGaD
Vincristine—NR0B1—Gene Expression—AKT1—melanoma	3.56e-06	6.22e-05	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—ERCC2—melanoma	3.55e-06	6.22e-05	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—FASN—melanoma	3.55e-06	6.2e-05	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—MYC—melanoma	3.55e-06	6.2e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—HPSE—melanoma	3.54e-06	6.19e-05	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—SLC5A5—melanoma	3.52e-06	6.16e-05	CbGpPWpGaD
Vincristine—ABCC1—Disease—FGF1—melanoma	3.5e-06	6.12e-05	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—SLC5A5—melanoma	3.49e-06	6.1e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—CUBN—melanoma	3.48e-06	6.08e-05	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—MAPK1—melanoma	3.47e-06	6.07e-05	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—EGFR—melanoma	3.47e-06	6.07e-05	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—GNAQ—melanoma	3.4e-06	5.95e-05	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—CD44—melanoma	3.4e-06	5.95e-05	CbGpPWpGaD
Vincristine—ABCC1—Disease—PDGFRA—melanoma	3.39e-06	5.92e-05	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—GNAQ—melanoma	3.37e-06	5.89e-05	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—CD44—melanoma	3.37e-06	5.89e-05	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—melanoma	3.37e-06	5.88e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—SDHD—melanoma	3.36e-06	5.87e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—CSPG4—melanoma	3.36e-06	5.87e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—BSG—melanoma	3.36e-06	5.87e-05	CbGpPWpGaD
Vincristine—ABCC1—Disease—PRKCA—melanoma	3.35e-06	5.86e-05	CbGpPWpGaD
Vincristine—ABCC1—Disease—ERCC2—melanoma	3.33e-06	5.82e-05	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—VCAN—melanoma	3.29e-06	5.75e-05	CbGpPWpGaD
Vincristine—ABCC1—Disease—MAP2K2—melanoma	3.28e-06	5.73e-05	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—KRAS—melanoma	3.28e-06	5.73e-05	CbGpPWpGaD
Vincristine—ABCC1—Metabolism of lipids and lipoproteins—PTEN—melanoma	3.27e-06	5.72e-05	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—CYP1B1—melanoma	3.26e-06	5.7e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—GPAM—melanoma	3.25e-06	5.68e-05	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—CYP1B1—melanoma	3.23e-06	5.65e-05	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—melanoma	3.18e-06	5.57e-05	CbGpPWpGaD
Vincristine—ABCC1—Disease—TERT—melanoma	3.12e-06	5.45e-05	CbGpPWpGaD
Vincristine—ABCC1—Disease—HLA-A—melanoma	3.12e-06	5.45e-05	CbGpPWpGaD
Vincristine—ABCC1—Disease—RAC1—melanoma	3.11e-06	5.44e-05	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—melanoma	3.1e-06	5.41e-05	CbGpPWpGaD
Vincristine—ABCB11—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	3.07e-06	5.37e-05	CbGpPWpGaD
Vincristine—SLC22A3—Metabolism—PIK3CG—melanoma	3.05e-06	5.34e-05	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—ABCB1—melanoma	3.05e-06	5.34e-05	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—melanoma	3.03e-06	5.3e-05	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—melanoma	3.03e-06	5.3e-05	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—PIK3CA—melanoma	3.01e-06	5.27e-05	CbGpPWpGaD
Vincristine—ABCC1—Disease—HIF1A—melanoma	2.98e-06	5.21e-05	CbGpPWpGaD
Vincristine—SLC22A3—Metabolism—PPARG—melanoma	2.95e-06	5.15e-05	CbGpPWpGaD
Vincristine—ABCC3—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	2.94e-06	5.15e-05	CbGpPWpGaD
Vincristine—ABCB11—Metabolism—PIK3CG—melanoma	2.93e-06	5.12e-05	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—TP53—melanoma	2.91e-06	5.09e-05	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—melanoma	2.88e-06	5.04e-05	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—melanoma	2.86e-06	5e-05	CbGpPWpGaD
Vincristine—ABCB11—Metabolism—PPARG—melanoma	2.83e-06	4.94e-05	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—PRKCA—melanoma	2.81e-06	4.91e-05	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—PIK3CG—melanoma	2.81e-06	4.91e-05	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—HRAS—melanoma	2.79e-06	4.87e-05	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—ERCC2—melanoma	2.79e-06	4.87e-05	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—CYP17A1—melanoma	2.78e-06	4.85e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—PLA2G6—melanoma	2.76e-06	4.83e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—PLCB4—melanoma	2.73e-06	4.77e-05	CbGpPWpGaD
Vincristine—ABCC1—Disease—NOS2—melanoma	2.71e-06	4.74e-05	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—PPARG—melanoma	2.71e-06	4.74e-05	CbGpPWpGaD
Vincristine—ABCC1—Disease—NOTCH1—melanoma	2.69e-06	4.7e-05	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—ABCB1—melanoma	2.69e-06	4.7e-05	CbGpPWpGaD
Vincristine—SLC22A3—Metabolism—PIK3CD—melanoma	2.69e-06	4.69e-05	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—IL6—melanoma	2.67e-06	4.66e-05	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—ABCB1—melanoma	2.66e-06	4.65e-05	CbGpPWpGaD
Vincristine—SLC22A3—Metabolism—ALB—melanoma	2.65e-06	4.63e-05	CbGpPWpGaD
Vincristine—ABCC1—Disease—CD80—melanoma	2.63e-06	4.6e-05	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	2.63e-06	4.6e-05	CbGpPWpGaD
Vincristine—ABCC1—Disease—APC—melanoma	2.63e-06	4.59e-05	CbGpPWpGaD
Vincristine—ABCC1—Disease—KIT—melanoma	2.63e-06	4.59e-05	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—GNA11—melanoma	2.62e-06	4.58e-05	CbGpPWpGaD
Vincristine—ABCC1—Disease—EGF—melanoma	2.6e-06	4.54e-05	CbGpPWpGaD
Vincristine—ABCB11—Metabolism—PIK3CD—melanoma	2.57e-06	4.5e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—SLC6A11—melanoma	2.57e-06	4.49e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—PIP4K2A—melanoma	2.57e-06	4.49e-05	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—FASN—melanoma	2.57e-06	4.49e-05	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—melanoma	2.54e-06	4.45e-05	CbGpPWpGaD
Vincristine—ABCB11—Metabolism—ALB—melanoma	2.54e-06	4.44e-05	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—SLC5A5—melanoma	2.52e-06	4.41e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—MTAP—melanoma	2.5e-06	4.36e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—VCAN—melanoma	2.48e-06	4.34e-05	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—PRKCA—melanoma	2.47e-06	4.32e-05	CbGpPWpGaD
Vincristine—ABCC1—Disease—BRAF—melanoma	2.47e-06	4.32e-05	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—PIK3CD—melanoma	2.47e-06	4.32e-05	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—AKT1—melanoma	2.46e-06	4.3e-05	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—ERCC2—melanoma	2.45e-06	4.29e-05	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—PRKCA—melanoma	2.45e-06	4.28e-05	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—GNAQ—melanoma	2.44e-06	4.26e-05	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—CD44—melanoma	2.44e-06	4.26e-05	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—ALB—melanoma	2.44e-06	4.26e-05	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—ERCC2—melanoma	2.43e-06	4.25e-05	CbGpPWpGaD
Vincristine—SLC22A3—Metabolism—PIK3CB—melanoma	2.34e-06	4.09e-05	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—CYP1B1—melanoma	2.34e-06	4.09e-05	CbGpPWpGaD
Vincristine—ABCC1—Disease—MAP2K1—melanoma	2.32e-06	4.06e-05	CbGpPWpGaD
Vincristine—SLC22A3—Metabolism—PTGS2—melanoma	2.32e-06	4.05e-05	CbGpPWpGaD
Vincristine—ABCC1—Disease—PIK3CD—melanoma	2.31e-06	4.04e-05	CbGpPWpGaD
Vincristine—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	2.31e-06	4.03e-05	CbGpPWpGaD
Vincristine—ABCB11—Metabolism—PIK3CB—melanoma	2.24e-06	3.92e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—LUM—melanoma	2.22e-06	3.89e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—PHGDH—melanoma	2.22e-06	3.89e-05	CbGpPWpGaD
Vincristine—ABCB11—Metabolism—PTGS2—melanoma	2.22e-06	3.89e-05	CbGpPWpGaD
Vincristine—ABCC1—Disease—FGF2—melanoma	2.21e-06	3.87e-05	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—PIK3CG—melanoma	2.2e-06	3.85e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—HPSE—melanoma	2.18e-06	3.81e-05	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—PIK3CB—melanoma	2.15e-06	3.76e-05	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	2.15e-06	3.75e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—CUBN—melanoma	2.14e-06	3.74e-05	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—PTGS2—melanoma	2.13e-06	3.73e-05	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—PPARG—melanoma	2.12e-06	3.71e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—CYP17A1—melanoma	2.09e-06	3.66e-05	CbGpPWpGaD
Vincristine—ABCC1—Disease—MDM2—melanoma	2.07e-06	3.62e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—SDHD—melanoma	2.07e-06	3.62e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—CSPG4—melanoma	2.07e-06	3.62e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—BSG—melanoma	2.07e-06	3.62e-05	CbGpPWpGaD
Vincristine—ABCC1—Disease—ERBB2—melanoma	2.04e-06	3.57e-05	CbGpPWpGaD
Vincristine—SLC22A3—Metabolism—PTEN—melanoma	2.02e-06	3.54e-05	CbGpPWpGaD
Vincristine—ABCC1—Disease—PIK3CB—melanoma	2.01e-06	3.52e-05	CbGpPWpGaD
Vincristine—ABCC1—Disease—CD4—melanoma	2.01e-06	3.51e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—GPAM—melanoma	2e-06	3.5e-05	CbGpPWpGaD
Vincristine—ABCC1—Disease—PTGS2—melanoma	1.99e-06	3.49e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—GNA11—melanoma	1.98e-06	3.46e-05	CbGpPWpGaD
Vincristine—ABCB1—Transmembrane transport of small molecules—ALB—melanoma	1.94e-06	3.39e-05	CbGpPWpGaD
Vincristine—ABCB11—Metabolism—PTEN—melanoma	1.94e-06	3.39e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—FASN—melanoma	1.94e-06	3.38e-05	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—PIK3CG—melanoma	1.94e-06	3.38e-05	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—PIK3CD—melanoma	1.93e-06	3.38e-05	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—ABCB1—melanoma	1.92e-06	3.36e-05	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—PIK3CG—melanoma	1.92e-06	3.35e-05	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—ALB—melanoma	1.91e-06	3.34e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—SLC5A5—melanoma	1.9e-06	3.33e-05	CbGpPWpGaD
Vincristine—ABCC1—Disease—CDKN1B—melanoma	1.89e-06	3.3e-05	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—PPARG—melanoma	1.87e-06	3.27e-05	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—PTEN—melanoma	1.86e-06	3.25e-05	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—PPARG—melanoma	1.85e-06	3.24e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—GNAQ—melanoma	1.84e-06	3.22e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—CD44—melanoma	1.84e-06	3.22e-05	CbGpPWpGaD
Vincristine—ABCC1—Disease—CTNNB1—melanoma	1.78e-06	3.12e-05	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—PRKCA—melanoma	1.77e-06	3.1e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—CYP1B1—melanoma	1.76e-06	3.08e-05	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—ERCC2—melanoma	1.76e-06	3.07e-05	CbGpPWpGaD
Vincristine—ABCC1—Disease—CDKN1A—melanoma	1.74e-06	3.05e-05	CbGpPWpGaD
Vincristine—ABCC1—Disease—PTEN—melanoma	1.74e-06	3.04e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—PLA2G6—melanoma	1.7e-06	2.98e-05	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—PIK3CD—melanoma	1.7e-06	2.98e-05	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—PIK3CD—melanoma	1.69e-06	2.95e-05	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—PIK3CB—melanoma	1.69e-06	2.95e-05	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—ALB—melanoma	1.68e-06	2.94e-05	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—PTGS2—melanoma	1.67e-06	2.92e-05	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—ALB—melanoma	1.67e-06	2.91e-05	CbGpPWpGaD
Vincristine—ABCC1—Disease—STAT3—melanoma	1.56e-06	2.72e-05	CbGpPWpGaD
Vincristine—ABCC1—Disease—NRAS—melanoma	1.55e-06	2.71e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—VCAN—melanoma	1.53e-06	2.67e-05	CbGpPWpGaD
Vincristine—ABCC1—Disease—MAPK3—melanoma	1.49e-06	2.6e-05	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—PIK3CB—melanoma	1.48e-06	2.59e-05	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—PIK3CB—melanoma	1.47e-06	2.57e-05	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—PTGS2—melanoma	1.47e-06	2.57e-05	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—PTGS2—melanoma	1.46e-06	2.55e-05	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—PTEN—melanoma	1.46e-06	2.55e-05	CbGpPWpGaD
Vincristine—ABCC1—Disease—MYC—melanoma	1.45e-06	2.53e-05	CbGpPWpGaD
Vincristine—SLC22A3—Metabolism—PIK3CA—melanoma	1.43e-06	2.49e-05	CbGpPWpGaD
Vincristine—ABCC1—Disease—MAPK1—melanoma	1.41e-06	2.47e-05	CbGpPWpGaD
Vincristine—ABCC1—Disease—EGFR—melanoma	1.41e-06	2.47e-05	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—PIK3CG—melanoma	1.39e-06	2.42e-05	CbGpPWpGaD
Vincristine—ABCB11—Metabolism—PIK3CA—melanoma	1.37e-06	2.39e-05	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—PPARG—melanoma	1.34e-06	2.34e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—PRKCA—melanoma	1.34e-06	2.34e-05	CbGpPWpGaD
Vincristine—ABCC1—Disease—KRAS—melanoma	1.34e-06	2.34e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—ERCC2—melanoma	1.33e-06	2.32e-05	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—PIK3CA—melanoma	1.31e-06	2.29e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—CYP17A1—melanoma	1.29e-06	2.26e-05	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—PTEN—melanoma	1.28e-06	2.24e-05	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—PTEN—melanoma	1.27e-06	2.22e-05	CbGpPWpGaD
Vincristine—ABCC1—Disease—PIK3CA—melanoma	1.23e-06	2.15e-05	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—PIK3CD—melanoma	1.22e-06	2.13e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—GNA11—melanoma	1.22e-06	2.13e-05	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—ALB—melanoma	1.2e-06	2.1e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—FASN—melanoma	1.19e-06	2.09e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—SLC5A5—melanoma	1.17e-06	2.05e-05	CbGpPWpGaD
Vincristine—SLC22A3—Metabolism—AKT1—melanoma	1.17e-06	2.04e-05	CbGpPWpGaD
Vincristine—ABCC1—Disease—HRAS—melanoma	1.14e-06	1.98e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—CD44—melanoma	1.13e-06	1.98e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—GNAQ—melanoma	1.13e-06	1.98e-05	CbGpPWpGaD
Vincristine—ABCB11—Metabolism—AKT1—melanoma	1.12e-06	1.95e-05	CbGpPWpGaD
Vincristine—ABCC1—Disease—IL6—melanoma	1.09e-06	1.9e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—CYP1B1—melanoma	1.09e-06	1.9e-05	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—AKT1—melanoma	1.07e-06	1.87e-05	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—PIK3CB—melanoma	1.06e-06	1.86e-05	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—PTGS2—melanoma	1.05e-06	1.84e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—PIK3CG—melanoma	1.05e-06	1.83e-05	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—PIK3CA—melanoma	1.03e-06	1.8e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—PPARG—melanoma	1.01e-06	1.77e-05	CbGpPWpGaD
Vincristine—ABCC1—Disease—AKT1—melanoma	1e-06	1.75e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—PIK3CD—melanoma	9.2e-07	1.61e-05	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—PTEN—melanoma	9.18e-07	1.61e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—ALB—melanoma	9.08e-07	1.59e-05	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—PIK3CA—melanoma	9.04e-07	1.58e-05	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—PIK3CA—melanoma	8.96e-07	1.57e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—ABCB1—melanoma	8.94e-07	1.56e-05	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—AKT1—melanoma	8.39e-07	1.47e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—PRKCA—melanoma	8.23e-07	1.44e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—ERCC2—melanoma	8.16e-07	1.43e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—PIK3CB—melanoma	8.02e-07	1.4e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—PTGS2—melanoma	7.95e-07	1.39e-05	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—AKT1—melanoma	7.39e-07	1.29e-05	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—AKT1—melanoma	7.32e-07	1.28e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—PTEN—melanoma	6.93e-07	1.21e-05	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—PIK3CA—melanoma	6.48e-07	1.13e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—PIK3CG—melanoma	6.45e-07	1.13e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—PPARG—melanoma	6.22e-07	1.09e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—PIK3CD—melanoma	5.67e-07	9.91e-06	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—ALB—melanoma	5.6e-07	9.78e-06	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—AKT1—melanoma	5.29e-07	9.25e-06	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—PIK3CB—melanoma	4.94e-07	8.64e-06	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—PTGS2—melanoma	4.9e-07	8.56e-06	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—PIK3CA—melanoma	4.89e-07	8.55e-06	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—PTEN—melanoma	4.27e-07	7.46e-06	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—AKT1—melanoma	3.99e-07	6.98e-06	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—PIK3CA—melanoma	3.01e-07	5.27e-06	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—AKT1—melanoma	2.46e-07	4.3e-06	CbGpPWpGaD
